Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects

NCT00811564 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

NCT00347841 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

NCT00541242 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin

NCT00759941 ·Status: COMPLETED ·Phase: PHASE4

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00314158 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)

NCT00698945 ·Status: COMPLETED ·Phase: PHASE4

Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

NCT00440011 ·Status: COMPLETED ·Phase: PHASE4

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00314171 ·Status: COMPLETED ·Phase: PHASE3

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00293800 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)

NCT00716742 ·Status: COMPLETED

Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)

NCT00758342 ·Status: TERMINATED ·Phase: PHASE4

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00333125 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Different Drugs on Ocular Surface Disease in Glaucoma Patients: a Prospective Randomised Study

NCT04896125 ·Status: UNKNOWN

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

NCT00300443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

NCT01068964 ·Status: COMPLETED ·Phase: NA

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

NCT00347802 ·Status: COMPLETED ·Phase: PHASE4

Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects

NCT00735449 ·Status: COMPLETED ·Phase: PHASE4

Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma

NCT00487214 ·Status: COMPLETED

Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH

NCT01721707 ·Status: WITHDRAWN ·Phase: PHASE3

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

NCT01830140 ·Status: COMPLETED ·Phase: PHASE3

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

NCT01309204 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Comparison of Xalatan and Azopt on POAG and OH

NCT01084902 ·Status: UNKNOWN ·Phase: NA

Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

NCT01284166 ·Status: WITHDRAWN ·Phase: PHASE3

A Study of Glaucoma or Ocular Hypertension in Patients Within the United States

NCT00800267 ·Status: COMPLETED ·Phase: PHASE3

Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients

NCT01151904 ·Status: TERMINATED ·Phase: PHASE4